A pilot Phase I study combining peptide-based vaccination and NGR-hTNF vessel targeting therapy in metastatic melanoma

Por Parmiani, Giorgio, Pilla, Lorenzo, Corti, Angelo, Doglioni, Claudio, Cimminiello, Carolina, Bellone, Matteo, Parolini, Danilo, Russo, Vincenzo, Capocefalo, Filippo, Maccalli, Cristina
Publicado no Oncoimmunology (2014)

Adjuvant FOLFOX-4 in patients with radically resected gastric cancer: Tolerability and prognostic factors

Por CARLOMAGNO, CHIARA, MATANO, ELIDE, BIANCO, ROBERTO, CIMMINIELLO, CAROLINA, PRUDENTE, ANTONELLA, PAGLIARULO, CLORINDO, CRISPO, ANNA, CANNELLA, LUCIA, DE STEFANO, ALFONSO, D’ARMIENTO, FRANCESCO PAOLO, DE PLACIDO, SABINO
Publicado em 2010

Clinical experience with ipilimumab 3 mg/kg: real-world efficacy and safety data from an expanded access programme cohort

Por Ascierto, Paolo A, Simeone, Ester, Sileni, Vanna Chiarion, Pigozzo, Jacopo, Maio, Michele, Altomonte, Maresa, Del Vecchio, Michele, Di Guardo, Lorenza, Marchetti, Paolo, Ridolfi, Ruggero, Cognetti, Francesco, Testori, Alessandro, Bernengo, Maria Grazia, Guida, Michele, Marconcini, Riccardo, Mandalà, Mario, Cimminiello, Carolina, Rinaldi, Gaetana, Aglietta, Massimo, Queirolo, Paola
Publicado em 2014